Nancy L. Bartlett - Publications, H-index & Citations

Nancy L. Bartlett

thomas jefferson university

96H指数

935论文数

4.7W被引数

收录论文 145

发表时间

Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphoma 免疫疗法单独或联合化疗作为边缘区淋巴瘤一线治疗的比较有效性

Haematologica

IF7.9

2026-05-01

PREAI

Olszewski, Adam J.; Ollila, Thomas A.; Chihara, Dai; Shouse, Geoffrey; Grover, Natalie; Karmali, Reem; Torka, Pallawi; Thomas, Colin; Geethakumari, Praveen Ramakrishnan; Barta, Stefan K.; Bartlett, Nancy L.; Epperla, Narendranath

Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma Brentuximab vedotin和nivolumab联合化疗治疗非巨大肿块、早期经典型霍奇金淋巴瘤

Blood

IF23.1

2026-04-01

PREAI

Abramson, Jeremy S.; Straus, David J.; Bartlett, Nancy L.; Burke, John M.; Lynch, Ryan C.; Domenech, Eva Domingo; Hess, Brian; Schuster, Steven R.; Linhares, Yuliya; Gandhi, Mitul; Shah, Harsh R.; Jurczak, Wojciech; Re, Alessandro; Hahn, Uwe; Prince, H. Miles; Guo, Wenchuan; Davis, Griffith; Ho, Linda; Fanale, Michelle; Yasenchak, Christopher A.; Lee, Hun Ju

Real-World Evidence for Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin in Classical Hodgkin Lymphoma 真实世界证据：帕博利珠单抗、吉西他滨、长春瑞滨和脂质体多柔比星在经典霍奇金淋巴瘤中的应用

Blood Advances

IF7.1

2026-03-23

OAAI

Grace Baek; Gaurav Varma; Samuel Yamshon; Herman van Besien; Nancy L. Bartlett; Marcus Watkins; Harsh R. Shah; Kelsey Baron; Reid W. Merryman; Ayo S. Falade; Jakub Svoboda; Sara Prischak; Christopher D’Angelo; Joe D. Lukowski; Ranjana H. Advani; Austin H Yeung; Maya Rosenberg; Jenna Voutsinas; Mengyang Di; Ryan Lynch

Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter’s transformation.Mosunetuzumab单药治疗在复发/难治性Richter’s transformation患者中是有效的且可耐受的。

Blood Advances

IF7.1

2026-02-09

OAAI

Katharine Louise Lewis; Sarit E Assouline; Ross Baker; Nancy L Bartlett; Dima El-Sharkawi; Pratyush Giri; Matthew Ku; Matthew Matasar; Stephen Schuster; John Radford; Michael C Wei; Shen Yin; Antonia Kwan; Iris To; Vibya Raghavan; Lihua E Budde; Chan Y Cheah

Evolving Treatment Options for Relapsed/Refractory Follicular Lymphoma

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2025-11-01

PREAI

Bartlett, Nancy L.

B-Cell Lymphomas 3.2025 Featured Updates to the NCCN Guidelines B细胞淋巴瘤 3.2025 NCCN指南特色更新

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2025-10-01

PREAI

Zelenetz, Andrew D.; Gordon, Leo I.; Abramson, Jeremy S.; Advani, Ranjana H.; Andreadis, Babis; Bartlett, Nancy L.; Budde, L. Elizabeth; Caimi, Paolo F.; Chang, Julie E.; Christian, Beth; DeVos, Sven; Dholaria, Bhagirathbhai; Fayad, Luis E.; Habermann, Thomas M.; Hamid, Muhammad Saad; Hernandez-Ilizaliturri, Francisco; Hu, Boyu; Karimi, Yasmin; Kelsey, Christopher R.; King, Rebecca; Kline, Justin; Krivacic, Susan; Lacasce, Ann S.; Landsburg, Daniel; Lim, Megan; Messmer, Marcus; Rabinovitch, Rachel; Ramakrishnan, Praveen; Reid, Erin; Roberts, Kenneth B.; Saeed, Hayder; Saito, Naoyuki G.; Smith, Stephen D.; Swinnen, Lode J.; Tuscano, Joseph; Vose, Julie M.; Dwyer, Mary; Sundar, Hema

Association of PET4 Response With Outcomes of BV-CHP vs CHOP in the ECHELON-2 Trial in CD30+ Peripheral T-cell Lymphoma PET4反应与ECHELON-2试验中CD30+外周T细胞淋巴瘤患者接受BV-CHP vs CHOP治疗的结局相关性研究

Blood Advances

IF7.1

2025-08-21

OAAI

Swaminathan Iyer; Neha Mehta-Shah; Ranjana Advani; Nancy L. Bartlett; Jacob H. Christensen; Franck Morschhauser; Eva Domingo-Domenech; Giuseppe Rossi; Won Seog Kim; Onder Alpdogan; Tatyana A. Feldman; Vincent Camus; Giuseppe Gritti; Pier Luigi Zinzani; David Belada; Jiri Mayer; Ilseung Choi; June-Won Cheong; Evelyn Rustia; Keenan Fenton

Camidanlumab Tesirine in Relapsed or Refractory Classic Hodgkin Lymphoma: A Phase 2 Study Camidanlumab Tesirine 在复发或难治性经典型霍奇金淋巴瘤中的应用：一项 II 期研究

Blood Advances

IF7.1

2025-08-19

OAAI

Alex F. Herrera; Stephen M. Ansell; Pier Luigi Zinzani; John Radford; Kami Maddocks; Antonio Pinto; Graham P. Collins; Veronika Bachanova; Nancy L. Bartlett; Isabelle Bence-Bruckler; Mehdi Hamadani; Justin Kline; Jiří Mayer; Kerry J. Savage; Ranjana H. Advani; Paolo F. Caimi; René-Olivier Casasnovas; Tatyana Feldman; Brian Hess; Mariana Bastos-Oreiro

Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up brentuximab vedotin联合化疗用于一线系统性间变性大细胞淋巴瘤的治疗：ECHELON-2研究5年随访的亚组分析

Blood Cancer Journal

IF11.6

2025-08-01

OAAI

Eva Domingo-Domènech; Barbara Pro; Tim Illidge; Steven Horwitz; Lorenz Trumper; Swami Iyer; Ranjana Advani; Nancy L. Bartlett; Jacob Haaber Christensen; Won-Seog Kim; Tatyana Feldman; Ilseung Choi; Giuseppe Gritti; David Belada; Andrei Shustov; Arpad Illes; Pier Luigi Zinzani; Andreas Hüttmann; Marek Trneny; Steven Le Gouill; Deepa Jagadeesh; Jonathan W. Friedberg; Meredith Little; Cassie Dong; Michelle Fanale; Keenan Fenton; Kerry J. Savage

Brentuximab vedotin and nivolumab for untreated patients with Hodgkin lymphoma: long-term results Brentuximab vedotin和nivolumab治疗初治霍奇金淋巴瘤患者：长期结果

Blood Advances

IF7.1

2025-05-05

OAAI

Bruce D. Cheson; Nancy L. Bartlett; Betsy Knopf; Hun J. Lee; Ranjana H. Advani; Beth Christian; Catherine S. Diefenbach; Tatyana A. Feldman; Stephen M. Ansell

Nivolumab plus relatlimab for patients with relapsed or progressed B-cell malignancies in RELATIVITY-022 纳武利尤单抗联合罗特利珠单抗治疗复发或进展性B细胞恶性肿瘤的RELATIVITY-022研究

Blood Advances

IF7.1

2025-03-05

OAAI

Ajay K. Gopal; Philippe Armand; Sattva S. Neelapu; Nancy L. Bartlett; Stephen E. Spurgeon; John Kuruvilla; Kerry J. Savage; John P. Leonard; Arnold B. Gelb; Nasir Ahmed; Shiqi Dong; Sai Praneeth Bathena; Rasika Suryawanshi; Jenny Qun Wu; Sheen Wang; Douglas E. Gladstone

Sequencing bispecific antibodies and CAR T cells for FL 测序双特异性抗体和CAR T细胞用于FL

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM

IF3.2

2024-12-06

PREAI

Russler-Germain, David A.; Bartlett, Nancy L.

Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab inpatients with relapsed/refractory large B-cell lymphoma 地塞米松与 glofitamab 预治疗中替代糖皮质激素方案相比，可降低大B细胞淋巴瘤复发/难治性患者细胞因子释放综合征的发生频率和强度。

HAEMATOLOGICA

IF7.9

2024-11-28

OAAI

Falchi, Lorenzo; Hutchings, Martin; Carlo-Stella, Carmelo; Morschhauser, Franck; Dickinson, Michael; Cartron, Guillaume; Khan, Cyrus; Tani, Monica; Martinez-Lopez, Joaquin; Bartlett, Nancy L.; Salar, Antonio; Brody, Joshua D.; Berthier, Aurelien; Kallemeijn, Martine; Relf, James; Tchaleu, Fabiola Bene; Lundberg, Linda; Bachy, Emmanuel

Addition or Substitution of Acalabrutinib in Intensive Frontline Chemoimmunotherapy for Patients ≤ 70 Years Old with Mantle Cell Lymphoma: Outcomes of the 3-Arm Randomized Phase II Intergroup Trial ECOG-ACRIN EA4181 在≤70岁套细胞淋巴瘤患者强化一线化疗免疫治疗中添加或替代Acalabrutinib：ECOG-ACRIN EA4181三臂随机Ⅱ期协作组试验的结果

BLOOD

IF23.1

2024-11-05

PREAI

Wagner-Johnston, Nina; Jegede, Opeyemi; Spurgeon, Stephen E.; Maddocks, Kami J.; Yang, David T.; Romanoff, Justin; Paludo, Jonas; Caimi, Paolo F.; Bartlett, Nancy L.; Reagan, Patrick M.; Sawalha, Yazeed; Hoffmann, Marc; Hu, Boyu; Aziz, Ashraf R.; Marques, Helga; Shields, Lale Kosakoglu; Leonard, John P.; Friedberg, Jonathan W.; Kahl, Brad S.

Long-Term Follow-up of Bendamustine/Rituximab- Rituximab/Cytarabine (BR/RC) Induction Therapy for Previously Untreated Transplant-Eligible Patients with Mantle Cell Lymphoma (MCL)bendamustine/Rituximab- Rituximab/Cytarabine (BR/RC)诱导治疗对先前未治疗的移植符合条件的套细胞淋巴瘤(MCL)患者的长期随访

BLOOD

IF23.1

2024-11-05

PREAI

Ryan, Christine E.; Nizamuddin, Imran A.; Raman, Hari S.; Redd, Robert A.; Watkins, Marcus P.; Lacasce, Ann S.; Fisher, David C.; Kim, Austin I.; Davids, Matthew S.; Jacobson, Caron A.; Odejide, Oreofe O.; Crombie, Jennifer L.; Mehta-Shah, Neha; Cashen, Amanda F.; Ghobadi, Armin; Bartlett, Nancy L.; Jacobsen, Eric D.; Armand, Philippe; Kahl, Brad S.; Merryman, Reid W.

Mosunetuzumab Monotherapy Demonstrates Encouraging Activity and a Manageable Safety Profile in Patients with Heavily Pre-Treated Relapsed or Refractory Mantle Cell Lymphoma Mosunetuzumab单药治疗在重度预治疗复发或难治性套细胞淋巴瘤患者中显示出令人鼓舞的疗效和可管理的安全性。

BLOOD

IF23.1

2024-11-05

PREAI

Budde, Elizabeth; Matasar, Matthew; Sehn, Laurie H.; Assouline, Sarit E.; Kuruvilla, John; Flinn, Ian W.; Yoon, Sung-Soo; Bosch, Francesc; Greenwald, Daniel; Gutierrez, Norma C.; Tzachanis, Dimitrios; Marlton, Paula; Mcguirt, Delaney; Yin, Shen; Wei, Michael C.; Kwan, Antonia; Tracy, Samuel; Penuel, Elicia; Bartlett, Nancy L.

Disrupting IL10 Signaling Overcomes Compound Copy Number Variation-Driven Clinical Resistance to CDK4/6 and BTK Inhibition in Mantle Cell Lymphoma 干扰IL10信号克服了复合拷贝数变异驱动的临床耐药性，对CDK4/6和BTK抑制在套细胞淋巴瘤中的作用

BLOOD

IF23.1

2024-11-05

PREAI

Di Liberto, Maurizio; Hu, Yang; Huang, Xiangao; Inghirami, Giorgio; Wang, Kevin; Lee, Christina Y.; Maddocks, Kami J.; Blum, Kristie A.; Ruan, Jia; Leonard, John P.; Bartlett, Nancy L.; Martin, Peter; Elemento, Olivier; Chen-Kiang, Selina

Representation of Minorities in Therapeutic Clinical Trials- a 15-Year Review of Lymphoma Cooperative Group Studies (Alliance A152123)少数民族在治疗性临床试验中的代表性——淋巴瘤协作组研究15年回顾 (Alliance A152123)

BLOOD

IF23.1

2024-11-05

PREAI

Alencar, Alvaro J.; Geyer, Susan M.; Paskett, Electra; Pederson, Levi D.; Dockter, Travis; Ghosh, Nilanjan; Adekola, Kehinde; Unger, Joseph M.; Jegede, Opeyemi; Friedberg, Jonathan W.; Kahl, Brad S.; Dinner, Shira N.; Bartlett, Nancy L.; Blum, Kristie A.; Leonard, John P.

Mosunetuzumab Continues to Demonstrate Clinically Meaningful Outcomes in Patients with Relapsed and/or Refractory Follicular Lymphoma after ≥ 2 Prior Therapies Including Those with a History of POD24: 4-Year Follow-up of a Pivotal Phase II Study Mosunetuzumab 在接受 ≥ 2 种既往治疗（包括有 POD24 病史者）的复发性和/或难治性滤泡性淋巴瘤患者中持续显示出具有临床意义的结果：一项关键性 II 期研究的 4 年随访结果

BLOOD

IF23.1

2024-11-05

PREAI

Shadman, Mazyar; Bartlett, Nancy L.; Matasar, Matthew; Schuster, Stephen J.; Assouline, Sarit E.; Sehn, Laurie H.; Kuruvilla, John; Giri, Pratyush; Cheah, Chan Y.; Dietrich, Sascha; Fay, Keith; Ku, Matthew; Nastoupil, Loretta; Wei, Michael C.; Yin, Shen; Ma, Connie Y.; Tracy, Samuel; Kwan, Antonia; Penuel, Elicia; Budde, L. Elizabeth

Trial in Progress- Alliance A052101: A Randomized Phase 3 Trial of Continuous Vs. Intermittent Maintenance Therapy with Zanubrutinib As Upfront Treatment in Older Patients with Mantle Cell Lymphoma 试验进行中-联盟A052101：一项关于在老年套细胞淋巴瘤患者中，作为一线治疗使用zanubrutinib进行持续与间歇维持治疗的随机III期试验

BLOOD

IF23.1

2024-11-05

PREAI

Beaven, Anne W.; Geyer, Susan M.; Cohen, Jonathon B.; Phillips, Tycel; Dockter, Travis; Pophali, Priyanka A.; Thanarajasingam, Gita; Mazza, Gina L.; Alencar, Alvaro J.; Dinner, Shira N.; Hsi, Eric D.; Welliver, Meng; Nikcevich, Daniel; Kahl, Brad S.; Friedberg, Jonathan W.; Bartlett, Nancy L.; Leonard, John P.

研究方向